Insider trade

Director sold ~$2.11M of KRYS shares in the open market

Traded Feb 19, 2026 · Filed Feb 24, 2026

Why it stands out

A Krystal Biotech director sold $2.11M of Krystal Biotech shares. The filing does not indicate a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$2,114,103

Shares × reported transaction price

Timing vs results

2 days after results of Feb 17, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−1.2%	−1.0%	−0.1%
30 days	−5.8%	−6.2%	+0.3%
90 days	+13.4%	+9.2%	+4.2%
180 days	+28.0%	+11.1%	+17.0%

Past results only. Not a forecast.

Scheduled in advanceFiled 7mo ago

Automatic saleFiled 7mo ago

Automatic saleFiled 7mo ago